Literature DB >> 7689297

Filgrastim (r-metHuG-CSF) reversal of drug-induced agranulocytosis.

A H Teitelbaum1, A J Bell, S L Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689297     DOI： 10.1016/0002-9343(93)90270-y

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  4 in total

Review 1.  Drug-induced myelosuppression : diagnosis and management.

Authors:  Peter J Carey
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

2.  G-CSF in gold-induced aplastic anaemia.

Authors:  S L Brown; E R Hill
Journal:  Ann Rheum Dis       Date:  1994-03       Impact factor: 19.103

3.  Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Authors:  H Demuynck; P Zachée; G E Verhoef; M Schetz; G Van den Berghe; P Lauwers; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

Review 4.  Filgrastim. A review of its pharmacological properties and therapeutic efficacy in neutropenia.

Authors:  J E Frampton; C R Lee; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.